Atlas Trials

Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients

Clinical trial NCT04524507 · COMPLETED

Trial details

NCT number
NCT04524507
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-08-27
Primary completion
2021-01-04
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.